Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
UBS
US Army
Cipla
Chubb
QuintilesIMS
Express Scripts
AstraZeneca

Generated: December 18, 2018

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

« Back to Dashboard

Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

Docket ➤ Sign Up Date Filed 2011-02-23
Court District Court, N.D. California Date Terminated 2013-11-01
Cause 35:271 Patent Infringement Assigned To Magistrate Judge Joseph C. Spe
Jury Demand None Referred To Magistrate Judge Jacqueline Sc
Parties HANDA PHARMACEUTICALS, LLC; IMPAX LABORATORIES, INC.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.; SANDOZ INC.; TAKEDA PHARMACEUTICAL CO., LTD; TAKEDA PHARMACEUTICALS AMERICA, INC; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC
Patents 4,628,098; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755; RE42,461
Attorneys Bruce D DeRenzi; Chantal Morgan D'Apuzzo; Chiemi Denise Suzuki; Edward George Dane; Frances Lu Pai; Heather E. Takahashi; Jacob Z. Zambrzycki; James K. Stronski ,; Jeffrey I. Weinberger; Jessica E. La Londe; Joel Matthew Purles; Keith J. Harrison; Mark T. Jansen; Parisa Jorjani; Payson James LeMeilleur; Ryan W. Koppelman; Steven Arthur Maddox; Ted G. Dane , Esq.; Tina Wang Arroyo; William Rolland Zimmerman
Firms Alston & Bird LLP; Morrison & Foerster LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for Takeda Pharmaceutical Co., LTD v. Handa Pharmaceuticals, LLC (N.D. Cal. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-04-11 106 following Takeda patents are at issue in the Actions: 1) U.S. Patent No. 6,462,058 (“the … 14 ’058 Patent”); 2) U.S. Patent No. 6,664,276 (“the ’276 Patent”); 3) U.S. Patent No. 6,939,971… 15 ’971 Patent”); 4) U.S. Patent No. 7,737,282 (“the ’282 Patent”); 5) U.S. Patent No. 7,285,668… 16 ’668 Patent”) and 6) U.S. Patent No. 7,790,755 (“the ’755 Patent”). … pharmaceutical patent, even if it is not in the same patent family as the ’282 patent. Id. at 7-8. External link to document
2011-04-29 30 record and assignee of U.S. Patent No. 6,462,058 (“the ‘058 Patent”), U.S. Patent No. … to be a copy of United States Patent No. 6,462,058 (“the ‘058 Patent”) titled “Benzimidazole 15 Compound…22 (Patent Infringement of U.S. Patent No. 6,462,058) 23 37. Handa… (Declaratory Judgment as to U.S. Patent Nos. 6,462,058, 6,664,576, …infringe 13 any valid claim of United States Patent Nos. 6,462,058, 6,664,276, 6,939,971, 7,285,668, and 14 External link to document
2013-04-30 336 Defendants. PATENT NO. 7,790,755 UNDER FED. R. …for Judgment of Non-Infringement of U.S. Patent No. 7,790,755 Under Fed. R. Civ. P. 4 54(b) (“54(b…' Motion for Judgment of Non-Infringement of US Patent '755 and Exhibit 2.(klhS, COURT STAFF) (Filed on…2011 1 November 2013 3:11-cv-00840-JCS Patent None District Court, N.D. California External link to document
2013-10-17 446 U.S. Patent 4,628,098 (TX 0097), also assigned to Takeda. 156. “Kohl” refers to Gerrnan Patent Application…the following patents: 1) U.S. Patent No. 6,462,058 (“the ’058 Patent”); 2) U.S. Patent No. 6,664,2766,664,276 (“the ’276 Patent”); 3) U.S. Patent No. 6,939,971 (“the ’971 Patent”); 4) U.S. Patent No. 7,737,282 … (“the ’282 Patent”); 5) U.S. Patent No. 7,285,668 (“the ’668 Patent”) and 6) U.S. Patent No. 7,790,755…TX 0001 (’058 Patent); TX 0002 (’276 Patent); TX 1054 (’971 Patent); TX 1055 (’282 Patent). All have essentially External link to document
2013-11-01 451 of U.S. Patent No. 6,664,276 (“the ’276 11 Patent”) and asserted claims 1 and 2 of U.S. Patent No. 7,737,282…as to Patent No.'276, and '282. Judgment is in favor of Handa/Par against Takeda as to '755 Patent. Signed…asserted claims 2, 4, and 6 of U.S. Patent No. 7,790,755 (“the ’755 Patent”); and it is 21 further, 22 …Page 3 of 4 1 and ’282 Patents (currently, June 15, 2020, for the ’282 Patent, and December 15, 2020,…the’276 Patent, which date is subject to extension 3 pursuant to Takeda’s request for patent term extension External link to document
2013-12-09 467 For Judgment of NonInfringement of U.S. Patent No. 7,790,755 Under Fed. R. Civ. P. 54(B) by Takeda Pharmaceutical…2011 1 November 2013 3:11-cv-00840-JCS Patent None District Court, N.D. California External link to document
2013-12-09 468 for Judgment of Noninfringement of U.S. Patent No. 7,790,755 Under FRCXP 54(B) [L.R. 7-9] by Takeda Pharmaceutical…2011 1 November 2013 3:11-cv-00840-JCS Patent None District Court, N.D. California External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
UBS
AstraZeneca
US Department of Justice
Accenture
Cantor Fitzgerald
McKinsey
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.